Artificially produced nerve conduits are promising alternatives to autologous nerve grafts in the treatment of damaged nerves. In this study, the physiochemical properties of chitosan/poly-ε-caprolactone nerve conduits will be improved by using the chitosan crosslinker genipin.
The use of microgels is one way of biomimetically mimicking tissue. In the presented study, chitosan microgels will be functionalized with Zn (II) and Cu (II) ions to improve their physicochemical properties.
After traveling the beautiful landscape of Iceland, our Chitosan crab is now on its way to Siglufjörður for EUCHIS 2023. We are very much looking forward to seeing everyone again and are excited about the scientific exchange. Besides Chitosan and our crab, we have great news in our luggage. Stay tuned!
Chitosan bioglass networks can be used as biomaterials in medicine, for example, as bone implants. Their physiochemical and mechanical properties can be improved by crosslinkers and various stabilization methods. In the presented study, six of them were compared with each other.
We are very pleased to announce that Katja Richter, CEO of Heppe Medical Chitosan GmbH, has been appointed to the scientific committee of EUCHIS 2023. EUCHIS 2023, the International Conference of the European Chitin Society (EUCHIS 2023) and the 15th International Conference on Chitin and Chitosan (15th ICCC) will be held in Siglufjörður, Iceland, from September 11-14, 2023.
In 2019, many interesting and innovative research articles about chitosan and chitosan derivatives were published. In this article we present you an overview which chitosan reserach topics were important in 2019.
Worldwide, our chitosan and chitosan derivatives are used in research. We created a list of scientific articles published in 2018 using chitosan from HMC. Nanoparticles from chitosan or chitosan derivatives were most frequently produced and tested for a wide variety of applications, mainly directed drug delivery and tissue engineering. Curious where to find chitosan by HMC in research?